Cargando…

Solvents to Fragments to Drugs: MD Applications in Drug Design

Simulations of molecular dynamics (MD) are playing an increasingly important role in structure-based drug discovery (SBDD). Here we review the use of MD for proteins in aqueous solvation, organic/aqueous mixed solvents (MDmix) and with small ligands, to the classic SBDD problems: Binding mode and bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Defelipe, Lucas A., Arcon, Juan Pablo, Modenutti, Carlos P., Marti, Marcelo A., Turjanski, Adrián G., Barril, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321499/ https://www.ncbi.nlm.nih.gov/pubmed/30544890 http://dx.doi.org/10.3390/molecules23123269

Ejemplares similares

Aromatic clusters in protein–protein and protein–drug complexes
por: Lanzarotti, Esteban, et al.
Publicado: (2020)

TuberQ: a Mycobacterium tuberculosis protein druggability database
por: Radusky, Leandro, et al.
Publicado: (2014)

Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
por: Burastero, Osvaldo, et al.
Publicado: (2022)

Protein Topology Determines Cysteine Oxidation Fate: The Case of Sulfenyl Amide Formation among Protein Families
por: Defelipe, Lucas A., et al.
Publicado: (2015)

Target-Pathogen: a structural bioinformatic approach to prioritize drug targets in pathogens
por: Sosa, Ezequiel J, et al.
Publicado: (2018)

VarQ: A Tool for the Structural and Functional Analysis of Human Protein Variants
por: Radusky, Leandro, et al.
Publicado: (2018)

From Genome to Drugs: New Approaches in Antimicrobial Discovery
por: Serral, Federico, et al.
Publicado: (2021)

The Structural Biology of Galectin-Ligand Recognition: Current Advances in Modeling Tools, Protein Engineering, and Inhibitor Design
por: Modenutti, Carlos P., et al.
Publicado: (2019)

First Whole-Genome Shotgun Sequence of a Promising Cellulase Secretor, Trichoderma koningiopsis Strain POS7
por: Castrillo, María Lorena, et al.
Publicado: (2017)

Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines
por: Cardama, Georgina A, et al.
Publicado: (2014)

Exploiting solvent effects in drug design and optimization
por: Truchon, Jean-Francois, et al.
Publicado: (2014)

Extracting Atomic Contributions to Binding Free Energy using Molecular Dynamics Simulations with Mixed Solvents (MDmix)
por: Alvarez-Garcia, Daniel, et al.
Publicado: (2022)

Concepts and Core Principles of Fragment-Based Drug Design
por: Kirsch, Philine, et al.
Publicado: (2019)

Systematic Assessment of Fragment Identification for Multitarget Drug Design
por: Brunst, Steffen, et al.
Publicado: (2021)

Fragments and hot spots in drug discovery
por: Vajda, Sandor, et al.
Publicado: (2015)

Comparing Binding Modes of Analogous Fragments Using NMR in Fragment-Based Drug Design: Application to PRDX5
por: Aguirre, Clémentine, et al.
Publicado: (2014)

An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets
por: Ramos, Pablo Ivan Pereira, et al.
Publicado: (2018)

Integrating Protein Interaction Surface Prediction with a Fragment-Based Drug Design: Automatic Design of New Leads with Fragments on Energy Surfaces
por: Torielli, Luca, et al.
Publicado: (2022)

In Silico Structure-Based Approach for Group Efficiency Estimation in Fragment-Based Drug Design Using Evaluation of Fragment Contributions
por: Shulga, Dmitry A., et al.
Publicado: (2022)

KinaseMD: kinase mutations and drug response database
por: Hu, Ruifeng, et al.
Publicado: (2020)

A computational protocol to fragment-based drug design at PDB scale
por: Moriaud, F, et al.
Publicado: (2008)

The rise of molecular simulations in fragment-based drug design (FBDD): an overview
por: Bissaro, Maicol, et al.
Publicado: (2020)

Pharmacophore Modeling for Anti-Chagas Drug Design Using the Fragment Molecular Orbital Method
por: Yoshino, Ryunosuke, et al.
Publicado: (2015)

Versatile applications of deep eutectic solvents in drug discovery and drug delivery systems: Perspectives and opportunities
por: Hayyan, Maan
Publicado: (2023)

Applications of (19)F-NMR in Fragment-Based Drug Discovery
por: Norton, Raymond S., et al.
Publicado: (2016)

Application of Fragment-Based Drug Discovery to Versatile Targets
por: Li, Qingxin
Publicado: (2020)

Docking, virtual high throughput screening and in silico fragment-based drug design
por: Zoete, Vincent, et al.
Publicado: (2009)

Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
por: Johansson, Maria U., et al.
Publicado: (2023)

Reactivity of Covalent Fragments and Their Role in Fragment Based Drug Discovery
por: McAulay, Kirsten, et al.
Publicado: (2022)

Design of ionic liquids containing glucose and choline as drug carriers, finding the link between QM and MD studies
por: Kalhor, Sepideh, et al.
Publicado: (2022)

Validation of an MD simulation approach for electrical field responsive micelles and their application in drug delivery
por: Razavi, Leila, et al.
Publicado: (2023)

Computational fragment-based drug design to explore the hydrophobic subpocket of the mitotic kinesin Eg5 allosteric binding site
por: Oguievetskaia, Ksenia, et al.
Publicado: (2010)

Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment‐Based Drug Design Facilitated by Dynamic Combinatorial Chemistry
por: Mondal, Milon, et al.
Publicado: (2016)

Omics data integration facilitates target selection for new antiparasitic drugs against TriTryp infections
por: Rivara-Espasandín, Martin, et al.
Publicado: (2023)

Discovery of a novel kinase hinge binder fragment by dynamic undocking
por: Rachman, Moira, et al.
Publicado: (2020)

Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD
por: Park, Ju Nyeong, et al.
Publicado: (2018)

Modelling drug adsorption in metal–organic frameworks: the role of solvent
por: Sose, Abhishek T., et al.
Publicado: (2021)

Genetics and genomic medicine in Argentina
por: Vishnopolska, Sebastián A., et al.
Publicado: (2018)

Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design
por: Meine, Rosanna, et al.
Publicado: (2018)

Fragment Linker Prediction Using the Deep Encoder-Decoder Network for PROTACs Drug Design
por: Kao, Chien-Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oo4oripft6qg31lokhag5r9jfm